All Stories

  1. From bench to bedside: translating the histone deacetylase inhibitors into prostate cancer therapies
  2. Endocrine-disrupting chemicals as prostate carcinogens
  3. Sensitive fluorescent detection of SARS-CoV-2 RNA using an enzymatic-based method
  4. A new approach for extracellular RNA recovery from Rhodovulum sulfidophilum
  5. Propolis Protects GC-1spg Spermatogonial Cells against Tert-Butyl Hydroperoxide-Induced Oxidative Damage
  6. Proteomic analysis of STEAP1 knockdown in human LNCaP prostate cancer cells
  7. Evaluation of Bile Salts on the Survival and Modulation of Virulence of Aliarcobacter butzleri
  8. Combined Therapies with Taxane-Based Chemotherapeutic Drugs in Prostate Cancer: Novel Insights and Future Directions
  9. Development of a novel electrochemical biosensor based on plastic antibodies for detection of STEAP1 biomarker in cancer
  10. Combined Therapies with Taxanes Based-Chemotherapeutic Drugs in Prostate Cancer: Novel Insights and Future Directions
  11. STEAP1 Knockdown Decreases the Sensitivity of Prostate Cancer Cells to Paclitaxel, Docetaxel and Cabazitaxel
  12. STEAP1 regulation and its influence modulating the response of LNCaP prostate cancer cells to bicalutamide, enzalutamide and apalutamide
  13. Mini-Bioreactor Platform for Membrane Protein Production in Komagataella pastoris
  14. A chromatographic network for the purification of detergent-solubilized six-transmembrane epithelial antigen of the prostate 1 from Komagataella pastoris mini-bioreactor lysates
  15. Vascular Response of Tetrabromobisphenol a in Rat Aorta: Calcium Channels Inhibition and Potassium Channels Activation
  16. Differential response of hepatocellular carcinoma glycolytic metabolism and oxidative stress markers after exposure to human amniotic membrane proteins
  17. Comprehensive Landscape of STEAP Family Members Expression in Human Cancers: Unraveling the Potential Usefulness in Clinical Practice Using Integrated Bioinformatics Analysis
  18. Pathways involved in the human vascular Tetrabromobisphenol A response: Calcium and potassium channels and nitric oxide donors
  19. Differential Response of Human Amniotic Membrane Proteins in Hepatocellular Carcinoma: Analysis of the Glycolytic Metabolism
  20. Promoter Demethylation Upregulates STEAP1 Gene Expression in Human Prostate Cancer: In Vitro and In Silico Analysis
  21. Natural Products as Protective Agents for Male Fertility
  22. Enhanced Stability of Detergent-Free Human Native STEAP1 Protein from Neoplastic Prostate Cancer Cells upon an Innovative Isolation Procedure
  23. UV-B filter octylmethoxycinnamate impaired the main vasorelaxant mechanism of human umbilical artery
  24. The Performance of Minicircle DNA Versus Parental Plasmid in p53 Gene Delivery Into HPV-18-Infected Cervical Cancer Cells
  25. Overexpression of regucalcin mitigates the ageing-related changes in oxidative stress and sperm quality
  26. Effects of di(2-etilhexil) phthalate on human umbilical artery
  27. Glycolysis Inhibition as a Strategy for Hepatocellular Carcinoma Treatment?
  28. 542 Overexpression of the Calcium-Binding Protein Regucalcin Mitigates the Age-Associated Changes in Oxidative Stress and Semen Quality
  29. Amniotic membrane extract differentially regulates human peripheral blood T cell subsets, monocyte subpopulations and myeloid dendritic cells
  30. Knockdown of STEAP1 inhibits cell growth and induces apoptosis in LNCaP prostate cancer cells counteracting the effect of androgens
  31. Targeting STEAP1 Protein in Human Cancer: Current Trends and Future Challenges
  32. Variability of MMP/TIMP and TGF-β1 Receptors throughout the Clinical Progression of Chronic Venous Disease
  33. The stem cell factor (SCF)/c-KIT system in carcinogenesis of reproductive tissues: What does the hormonal regulation tell us?
  34. The protective effect of regucalcin against radiation-induced damage in testicular cells
  35. The Emerging Role of Regucalcin as a Tumor Suppressor: Facts and Views
  36. Endogenous Factors in the Recovery of Reproductive Function After Testicular Injury and Cancer
  37. Liver diseases: what is known so far about the therapy with human amniotic membrane?
  38. Regucalcin in hormone-dependent cancers: towards a candidate tumour suppressor gene?
  39. Effect of TGF-beta1 on MMP/TIMP and TGF-beta1 receptors in great saphenous veins and its significance on chronic venous insufficiency
  40. Oligoadenylate synthetase 1 (OAS1) expression in human breast and prostate cancer cases, and its regulation by sex steroid hormones
  41. Oxidative Stress, DNA, Cell Cycle/Cell Cycle Associated Proteins and Multidrug Resistance Proteins: Targets of Human Amniotic Membrane in Hepatocellular Carcinoma
  42. Advances in time course extracellular production of human pre-miR-29b from Rhodovulum sulfidophilum
  43. Estrogens down-regulate the stem cell factor (SCF)/c-KIT system in prostate cells: Evidence of antiproliferative and proapoptotic effects
  44. Aging-associated changes in oxidative stress, cell proliferation, and apoptosis are prevented in the prostate of transgenic rats overexpressing regucalcin
  45. Suppressed glycolytic metabolism in the prostate of transgenic rats overexpressing calcium-binding protein regucalcin underpins reduced cell proliferation
  46. Selective cytotoxicity and cell death induced by human amniotic membrane in hepatocellular carcinoma
  47. Effect of extracellular calcium on regucalcin expression and cell viability in neoplastic and non-neoplastic human prostate cells
  48. 5α-Dihydrotestosterone regulates the expression of L-type calcium channels and calcium-binding protein regucalcin in human breast cancer cells with suppression of cell growth
  49. Androgens enhance the glycolytic metabolism and lactate export in prostate cancer cells by modulating the expression of GLUT1, GLUT3, PFK, LDH and MCT4 genes
  50. Paradoxical and contradictory effects of imatinib in two cell line models of hormone-refractory prostate cancer
  51. Evaluation of MutS and Mut+ Pichia pastoris Strains for Membrane-Bound Catechol-O-Methyltransferase Biosynthesis
  52. Biochemical Properties of Amniotic Membrane
  53. Histopathological and in vivo evidence of regucalcin as a protective molecule in mammary gland carcinogenesis
  54. Hormonal regulation of c-KIT receptor and its ligand: implications for human infertility?
  55. Trends in Protein-Based Biosensor Assemblies for Drug Screening and Pharmaceutical Kinetic Studies
  56. Evaluation of the prebiotic potential of arabinoxylans from brewer’s spent grain
  57. 752: Anti-cancer proteins found in amniotic membrane: extraction, identification and cellular effects
  58. 750: Human amniotic membrane secreted factors plus chemotherapy: A mishmash of effects?
  59. Regucalcin is an androgen-target gene in the rat prostate modulating cell-cycle and apoptotic pathways
  60. Expression of STEAP1 and STEAP1B in prostate cell lines, and the putative regulation of STEAP1 by post-transcriptional and post-translational mechanisms
  61. Improved Minicircle DNA Biosynthesis for Gene Therapy Applications
  62. Effect of Amniotic Membrane Proteins in Human Cancer Cell Lines: An Exploratory Study
  63. STEAP1 is overexpressed in prostate cancer and prostatic intraepithelial neoplasia lesions, and it is positively associated with Gleason score
  64. Pichia pastoris: A Recombinant Microfactory for Antibodies and Human Membrane Proteins
  65. The diverse roles of calcium-binding protein regucalcin in cell biology: from tissue expression and signalling to disease
  66. Long- and short-term effects of androgens in human umbilical artery smooth muscle
  67. Beyond the Limits of Oxygen: Effects of Hypoxia in a Hormone-Independent Prostate Cancer Cell Line
  68. Androgen-responsive and nonresponsive prostate cancer cells present a distinct glycolytic metabolism profile
  69. Six transmembrane epithelial antigen of the prostate 1 is down-regulated by sex hormones in prostate cells
  70. A new strategy for RNA isolation from eukaryotic cells using arginine affinity chromatography
  71. 172 Expression of Apoptosis and Cell-cycle Regulators in Rat Prostate Overexpressing Regucalcin
  72. 177 Effect of Androgens on the Expression of Ca2+-binding Protein, Regucalcin, and Ca2+-channels in MCF-7 Cells
  73. 179 Regulation of STEAP1 Expression in Prostate by Sex Steroid Hormones
  74. Amniotic membrane: from structure and functions to clinical applications
  75. STEAP Proteins: From Structure to Applications in Cancer Therapy
  76. A novel prokaryotic expression system for biosynthesis of recombinant human membrane-bound catechol-O-methyltransferase
  77. Impact of plasmid induction strategy on overall plasmid DNA yield and E. coli physiology using flow cytometry and real-time PCR
  78. Monitoring plasmid DNA induction strategies using multi-parameter flow cytometry and real-time PCR
  79. Regucalcin is under-expressed in human breast and prostate cancers: Effect of sex steroid hormones
  80. STEAP1 is over-expressed in breast cancer and down-regulated by 17β-estradiol in MCF-7 cells and in the rat mammary gland
  81. Characterization of oligoadenylate synthetase-1 expression in rat mammary gland and prostate: effects of 17β-estradiol on the regulation of OAS1g in both tissues
  82. Regucalcin is expressed in rat mammary gland and prostate and down-regulated by 17β-estradiol